SE452011B - Ergopeptinderivat, forfarande for deras framstellning och farmaceutiska kompositioner innehallande dessa derivat - Google Patents

Ergopeptinderivat, forfarande for deras framstellning och farmaceutiska kompositioner innehallande dessa derivat

Info

Publication number
SE452011B
SE452011B SE8204585A SE8204585A SE452011B SE 452011 B SE452011 B SE 452011B SE 8204585 A SE8204585 A SE 8204585A SE 8204585 A SE8204585 A SE 8204585A SE 452011 B SE452011 B SE 452011B
Authority
SE
Sweden
Prior art keywords
hydrogen
carbon atoms
alkyl group
formula
acid addition
Prior art date
Application number
SE8204585A
Other languages
English (en)
Swedish (sv)
Other versions
SE8204585L (sv
SE8204585D0 (sv
Inventor
H Kobel
J-J Sanglier
H Tscherter
G Bolliger
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of SE8204585D0 publication Critical patent/SE8204585D0/xx
Publication of SE8204585L publication Critical patent/SE8204585L/xx
Publication of SE452011B publication Critical patent/SE452011B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains three hetero rings
    • C07D513/14—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • C07D519/02—Ergot alkaloids of the cyclic peptide type

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Plant Substances (AREA)
SE8204585A 1981-08-07 1982-08-05 Ergopeptinderivat, forfarande for deras framstellning och farmaceutiska kompositioner innehallande dessa derivat SE452011B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH5104/81A CH649300A5 (de) 1981-08-07 1981-08-07 Ergopeptinderivate, ihre herstellung und verwendung.

Publications (3)

Publication Number Publication Date
SE8204585D0 SE8204585D0 (sv) 1982-08-05
SE8204585L SE8204585L (sv) 1983-02-08
SE452011B true SE452011B (sv) 1987-11-09

Family

ID=4287999

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8204585A SE452011B (sv) 1981-08-07 1982-08-05 Ergopeptinderivat, forfarande for deras framstellning och farmaceutiska kompositioner innehallande dessa derivat

Country Status (27)

Country Link
US (3) US4542135A (fi)
JP (1) JPS5843982A (fi)
AT (1) AT382156B (fi)
AU (1) AU558414B2 (fi)
BE (1) BE894046A (fi)
CA (1) CA1191802A (fi)
CH (1) CH649300A5 (fi)
CS (1) CS235303B2 (fi)
DD (2) DD211582A5 (fi)
DE (1) DE3228230A1 (fi)
DK (1) DK352082A (fi)
ES (2) ES8402348A1 (fi)
FI (1) FI72979C (fi)
FR (1) FR2511003B1 (fi)
GB (1) GB2109795B (fi)
GR (1) GR77262B (fi)
HU (2) HU190405B (fi)
IE (1) IE53647B1 (fi)
IL (1) IL66471A (fi)
IT (1) IT1152489B (fi)
MY (1) MY8600311A (fi)
NL (1) NL8203067A (fi)
NZ (1) NZ201504A (fi)
PH (1) PH22998A (fi)
PT (1) PT75384B (fi)
SE (1) SE452011B (fi)
ZA (1) ZA825727B (fi)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH649300A5 (de) * 1981-08-07 1985-05-15 Sandoz Ag Ergopeptinderivate, ihre herstellung und verwendung.
JPS60104129A (ja) * 1983-11-11 1985-06-08 Hitachi Ltd フッ素含有ポリアミド酸誘導体及びポリイミドの製造方法
HU195729B (en) * 1985-02-05 1988-07-28 Sandoz Ag Process for producing pharmaceutical compositions containing 9,10-dihydro-ergot-alkaloides
HU193317B (en) * 1985-06-12 1987-09-28 Richter Gedeon Vegyeszet Process for producing 2-bromo-alpha-ergochristin
CA2125288C (en) * 1992-12-24 2004-11-23 Sergio Mantegani Serotoninergic ergoline derivatives
DE10041478A1 (de) 2000-08-24 2002-03-14 Sanol Arznei Schwarz Gmbh Neue pharmazeutische Zusammensetzung
DE10334188B4 (de) * 2003-07-26 2007-07-05 Schwarz Pharma Ag Verwendung von Rotigotin zur Behandlung von Depressionen
DE10334187A1 (de) * 2003-07-26 2005-03-03 Schwarz Pharma Ag Substituierte 2-Aminotetraline zur Behandlung von Depressionen
DE10361258A1 (de) * 2003-12-24 2005-07-28 Schwarz Pharma Ag Verwendung von substituierten 2-Aminotetralinen zur vorbeugenden Behandlung von Morbus Parkinson
US20050197385A1 (en) * 2004-02-20 2005-09-08 Schwarz Pharma Ag Use of rotigotine for treatment or prevention of dopaminergic neuron loss
DE102004014841B4 (de) * 2004-03-24 2006-07-06 Schwarz Pharma Ag Verwendung von Rotigotin zur Behandlung und Prävention des Parkinson-Plus-Syndroms
US20070022720A1 (en) * 2005-07-27 2007-02-01 The Toro Company Cleaner for cooling system screen of outdoor power equipment unit
SG181896A1 (en) * 2009-12-23 2012-07-30 Map Pharmaceuticals Inc Novel ergoline analogs
US8604035B2 (en) 2011-06-23 2013-12-10 Map Pharmaceuticals, Inc. Fluoroergoline analogs
SG11201403434YA (en) 2011-12-19 2014-09-26 Map Pharmaceuticals Inc Novel iso-ergoline derivatives
EP2793583A4 (en) 2011-12-21 2015-08-12 Map Pharmaceuticals Inc NOVEL NEUROMODULATORY CONNECTIONS
US9012640B2 (en) 2012-06-22 2015-04-21 Map Pharmaceuticals, Inc. Cabergoline derivatives
CZ304709B6 (cs) * 2013-07-25 2014-09-03 Teva Czech Industries S.R.O. Izolovaný kmen houby Claviceps purpurea (Fr.) Tul., CCM 8404
CN113308442B (zh) * 2021-04-28 2023-06-27 天津大学 重组酿酒酵母菌株及其构建方法

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3314959A (en) * 1961-05-10 1967-04-18 Sandoz Ltd Intermediates for the synthesis of ergot alkaloids
FR2292M (fr) * 1962-06-27 1964-01-27 Sandoz Sa Médicament a base d'une combinaison de dihydro-ergotamine, de caféine et d'une hydantoine.
CH602765A5 (fi) * 1974-09-27 1978-07-31 Sandoz Ag
CH602766A5 (en) * 1974-09-27 1978-07-31 Sandoz Ag 10-Alpha-methoxy-di:hydro-beta-ergosine derivs.
DE2750090A1 (de) * 1976-11-19 1978-06-01 Sandoz Ag Neue verabreichungsformen fuer organische verbindungen
CH626373A5 (fi) * 1977-02-22 1981-11-13 Sandoz Ag
GB1584464A (en) * 1977-04-19 1981-02-11 Farmaceutici Italia Ergot alkaloids
DE2717953A1 (de) * 1977-04-22 1978-10-26 Sandoz Ag Neue therapeutische mischung und verfahren zu deren herstellung
YU216177A (en) * 1977-09-09 1984-02-29 Rudolf Rucman Process for preparing 2-bromo ergosine
CH636011A5 (en) * 1978-01-01 1983-05-13 Sandoz Ag Administration forms for organic compounds
DE2962303D1 (en) * 1978-01-20 1982-04-29 Sandoz Ag Derivatives of ergopeptide alkaloids, process for their preparation and pharmaceutical compositions containing them
DE2803543A1 (de) * 1978-01-27 1979-08-02 Sandoz Ag Ergopeptidalkaloidderivate, ihre verwendung und herstellung
YU40046B (en) * 1978-09-04 1985-06-30 Lek Tovarna Farmacevtskih Process for preparing 2-bromo-9,10-dihydroergosine
US4609731A (en) * 1979-10-10 1986-09-02 Sandoz Ltd. Process for brominating ergot alkaloids
DD200571A1 (de) * 1981-07-22 1983-05-18 Alfred Baumert Verfahren zur herstellung von ergopeptinen mit modifiziertem prolinteil
CH649300A5 (de) * 1981-08-07 1985-05-15 Sandoz Ag Ergopeptinderivate, ihre herstellung und verwendung.

Also Published As

Publication number Publication date
FI72979C (fi) 1987-08-10
NL8203067A (nl) 1983-03-01
NZ201504A (en) 1986-08-08
JPH0437836B2 (fi) 1992-06-22
SE8204585L (sv) 1983-02-08
DE3228230A1 (de) 1983-02-17
CS235303B2 (en) 1985-05-15
DK352082A (da) 1983-02-08
MY8600311A (en) 1986-12-31
ATA302682A (de) 1986-06-15
IT8222768A0 (it) 1982-08-06
FI822670A0 (fi) 1982-07-30
SE8204585D0 (sv) 1982-08-05
IE821906L (en) 1983-02-07
FR2511003B1 (fr) 1986-12-05
GB2109795A (en) 1983-06-08
US4542135A (en) 1985-09-17
DD211582A5 (de) 1984-07-18
ZA825727B (en) 1984-03-28
AU558414B2 (en) 1987-01-29
ES8504825A1 (es) 1985-04-16
US4681880A (en) 1987-07-21
FI822670L (fi) 1983-02-08
ES514766A0 (es) 1984-01-16
BE894046A (fr) 1983-02-07
ES526119A0 (es) 1985-04-16
IL66471A0 (en) 1982-12-31
ES8402348A1 (es) 1984-01-16
CA1191802A (en) 1985-08-13
FR2511003A1 (fr) 1983-02-11
IE53647B1 (en) 1989-01-04
DD206379A5 (de) 1984-01-25
IT1152489B (it) 1986-12-31
PH22998A (en) 1989-02-24
AU8678582A (en) 1983-03-03
HU190405B (en) 1986-09-29
JPS5843982A (ja) 1983-03-14
HUT37960A (en) 1986-03-28
AT382156B (de) 1987-01-26
IL66471A (en) 1986-02-28
FI72979B (fi) 1987-04-30
PT75384A (en) 1982-09-01
US4804660A (en) 1989-02-14
PT75384B (en) 1985-06-28
HU193373B (en) 1987-09-28
GR77262B (fi) 1984-09-11
GB2109795B (en) 1985-07-03
CH649300A5 (de) 1985-05-15

Similar Documents

Publication Publication Date Title
SE452011B (sv) Ergopeptinderivat, forfarande for deras framstellning och farmaceutiska kompositioner innehallande dessa derivat
AU628370B2 (en) Tricyclic benzodiazepine derivatives
CN105518005A (zh) 作为rock抑制剂的三环吡啶-甲酰胺衍生物
US5541209A (en) Method of treating or preventing cardiac arrhythmia employing an N-substituted heterocyclic derivative
CZ145398A3 (cs) Cyklické a heterocyklické N-substituované alfa-iminohydroxamové a -karboxylové kyseliny, způsob jejich přípravy, léčivo, které je obsahuje a jejich použití
AU2005294329A1 (en) Thienopyridinone compounds and methods of treatment
WO1992012154A1 (en) Imidazotriazine derivatives
US5763454A (en) Crystal form of anhydrous 7-( 1α,5α,6α!-6-amino-3-azabicyclo 3.1.0!hex-3-yl)-6-fluoro-1-(2,4-difluorophenyl)-1,4-dihydro-4-oxo-1,8 naphthyridine-3-carboxylic acid, methanessulfonic acid salt
WO2005085245A1 (en) Pyrrolopyridine-2-carboxylic acid hydrazides
JP2021534106A (ja) Ｐａｄ４阻害剤としての置換チエノピロール
ES2355729T3 (es) Nuevos polimorfos cristalinos del clopidogrel.
CS262692B2 (en) Process for preparing new derivatives of 1h,3h-pyrrolo-/1,2-c/thiazole
WO1992017473A1 (en) Crystalline tiagabine hydrochloride monohydrate, its preparation and use
EP0173520B1 (en) Tricyclic oxindole antiinflammatory agents
KR100192833B1 (ko) 4-이실아미노피리딘 유도체 및 그의 제조방법
CS197276B2 (en) Method of producing new 1,5,10,10a-tetrahydrothiazolo/3,4-b/isoquinolines
DK146129B (da) Analogifremgangsmaade til fremstilling af ergopeptidalkaloidderivater
US4539402A (en) Quinazolinone derivatives
KR0128975B1 (ko) 9-아실아미노-테트라히드로아크리딘 유도체 및 그 유도체를 활성 성분으로 포함하는 기억력 촉진제
FI83869C (fi) Foerfarande foer framstaellning av nya terapeutiskt anvaendbara ergolinderivat.
SE455097B (sv) Peptidergotalkaloider, forfarande for deras framstellning och farmaceutisk komposition
KR0139946B1 (ko) 신규한 피리돈 카르본산 유도체 및 그의 제조방법
EP0847400A1 (en) Polymorphs of the prodrug 6-n-(l-ala-l-ala)-trovafloxacin
CN115403581A (zh) 作为irak4抑制剂的新型杂环化合物
PT100593A (pt) 3-aril-beta-carbolinas ou 3-heteroaril-beta-carbolinas, processos para a sua preparacao e composicoes farmaceuticas que as contem

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 8204585-7

Effective date: 19910315

Format of ref document f/p: F